503B Docket

Molecular PharmaGroup 503B outsourcing facility · New Providence, NJ

This is a record of what FDA published, not a rating. Last FDA inspection and Form 483 status below are as published in FDA's registered outsourcing facilities table (as of Sep 30, 2026).

FDA registration record

Listed by FDA asMolecular PharmaGroup, New Providence, NJ
City / stateNew Providence, NJ
FDA's table lists city and state only, not a street address.
Contact phone (as listed by FDA)908-588-3440
Initial registration date5/8/2018
Most recent registration date12/30/2025
Outsourcing facilities must re-register annually (Oct 1 – Dec 31) to remain on FDA's list.
Last inspection (FDA table)8/11/2025
Form 483 issued at last inspection?Yes · View Form 483 (FDA PDF)
Recall conducted? (FDA table)No
Action based on last inspectionUntitled Letter Issued 2/5/2026
“Open” means FDA has not determined whether further action will be taken (per FDA's table notes).
Intends to compound sterile drugs from bulk substancesYes
Self-reported by the facility at registration; FDA notes this information has not been verified by FDA.

Source: FDA Registered Outsourcing Facilities

Published FDA records

1Form 483 records
0Warning letters
0Recall events (openFDA)
0Uncertain-match items

Counts include only items from FDA's table or exact name + city + state matches. They are counts of published records, not a score. Uncertain matches are shown below but not counted.

State board of pharmacy license lookup

New Jersey Board of Pharmacy License Verification (license lookup)

Search the state board's lookup for this facility's license status and any disciplinary actions. We link to the state-level tool only and do not list license numbers. FDA's table does not include state board actions. Facilities that ship across state lines may also hold non-resident licenses in your state, so check your own state's board too.

Verify directly

Represent this facility? Claim this profile. Claimed profiles never change FDA records.

Timeline of FDA actions

Newest first. Sources: FDA's registration table, FDA's compounding actions page (2019 onward on the live page), and openFDA drug enforcement records. Items marked Uncertain match may relate to a different site or entity and are not counted. How matching works.

  1. FMD-145 letter Matched
    FMD-145 Letter Issued 04/8/2026
    Listed on FDA page under: Molecular PharmaGroup, LLC, New Providence, NJ - 503B Facility
    No document link published · FDA Compounding: Inspections, Recalls, and other Actions
  2. Untitled letter FDA table
    Untitled Letter Issued 2/5/2026; document link from FDA's compounding actions page ("Untitled Letter Issued 02/05/2026 (PDF - 858 KB)")
    FDA document · FDA registered outsourcing facilities table
  3. Inspection FDA table
    Last inspection per FDA table; Form 483 issued: Yes
    FDA document · FDA registered outsourcing facilities table
  4. Form FDA 483 FDA table
    Form FDA 483 (linked from FDA's registration table)
    FDA document · FDA registered outsourcing facilities table
  5. FMD-145 letter Matched
    FMD-145 Letter Issued 03/18/2024
    Listed on FDA page under: Molecular PharmaGroup, LLC, New Providence, NJ - 503B Facility
    No document link published · FDA Compounding: Inspections, Recalls, and other Actions